Skip to content
10-Q

Quarterly Report

RVL Pharmaceuticals plc

0001558370-23-009404

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 99.35M sh
Shares Diluted Q1 2023 · Mar 31, 2023 99.32M sh
Shares Diluted Q1 2023 · Mar 31, 2022 83.49M sh
Capex Q1 2023 · Mar 31, 2023 $1.3M
Capex Q1 2023 · Mar 31, 2022 $27K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$5.82M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$13.28M
Long Term Debt Q1 2023 · Mar 31, 2023 $67.13M
Short Term Debt Q1 2023 · Mar 31, 2023 $4.15M
Short Term Debt Q1 2023 · Dec 31, 2022 $1.43M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $32.64M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $44.54M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $26.34M
Cash And Equivalents Q1 2023 · Dec 31, 2021 $40.44M
Stockholders Equity Q1 2023 · Mar 31, 2023 $40M
Stockholders Equity Q1 2023 · Dec 31, 2022 $51.09M
Stockholders Equity Q1 2023 · Mar 31, 2022 $69.48M
Stockholders Equity Q1 2023 · Dec 31, 2021 $76.73M
Current Liabilities Q1 2023 · Mar 31, 2023 $16.41M
Current Liabilities Q1 2023 · Dec 31, 2022 $19.72M
Total Liabilities Q1 2023 · Mar 31, 2023 $71.11M
Total Liabilities Q1 2023 · Dec 31, 2022 $77.42M
Current Assets Q1 2023 · Mar 31, 2023 $38.35M
Current Assets Q1 2023 · Dec 31, 2022 $56.98M
Total Assets Q1 2023 · Mar 31, 2023 $111.11M
Total Assets Q1 2023 · Dec 31, 2022 $128.51M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.12
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.08
Eps Basic Q1 2023 · Mar 31, 2023 −$0.12
Eps Basic Q1 2023 · Mar 31, 2022 −$0.08
Sga Expense Q1 2023 · Mar 31, 2023 $16.2M
Sga Expense Q1 2023 · Mar 31, 2022 $23.83M
Rd Expense Q1 2023 · Mar 31, 2023 $626K
Rd Expense Q1 2023 · Mar 31, 2022 $862K
Net Income Q1 2023 · Mar 31, 2023 −$11.61M
Net Income Q1 2023 · Mar 31, 2022 −$6.82M
Operating Income Q1 2023 · Mar 31, 2023 −$10.29M
Operating Income Q1 2023 · Mar 31, 2022 −$5.4M
Gross Profit Q1 2023 · Mar 31, 2023 $6.53M
Gross Profit Q1 2023 · Mar 31, 2022 $19.3M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $2.3M
Cost Of Revenue Q1 2023 · Mar 31, 2022 $2.14M
Revenue Q1 2023 · Mar 31, 2023 $8.83M
Revenue Q1 2023 · Mar 31, 2022 $21.44M